Exploring AngioDynamics, Inc. (ANGO) Investor Profile: Who’s Buying and Why?

Have you ever wondered who the major players are behind AngioDynamics, Inc. (ANGO), and what drives their investment decisions? As of April 2025, institutional investors hold a significant 78.05% stake in AngioDynamics. Leading the pack are giants like BlackRock, Inc., holding 3,941,630 shares valued at approximately $35.91 million, and Systematic Financial Management, L.P., with 2,521,065 shares worth around $22.97 million. What strategies are these top holders employing, and how might their actions impact the future of ANGO? Let's delve into the investor profile of AngioDynamics to uncover the motivations and movements shaping this medical technology company.

AngioDynamics, Inc. (ANGO) Who Invests in AngioDynamics, Inc. (ANGO) and Why?

Understanding the investor profile of AngioDynamics, Inc. (ANGO) involves examining the various types of investors, their motivations, and the strategies they employ. A diverse investor base can indicate a healthy market interest in the company, while concentrated ownership may suggest specific expectations or concerns regarding the company's performance.

Key investor types in AngioDynamics, Inc. (ANGO) typically include:

• Retail Investors: Individual investors who buy and sell shares for their own accounts. Their investment decisions are often based on personal research, recommendations, or market trends.
• Institutional Investors: These are entities that pool large sums of money to invest, such as pension funds, mutual funds, insurance companies, and endowments. Their investments are driven by detailed analysis and long-term strategies.
• Hedge Funds: Investment partnerships that use more aggressive strategies, such as leveraging or short-selling, to generate higher returns. They cater to accredited investors and institutions.

The motivations behind investing in AngioDynamics, Inc. (ANGO) can vary:

• Growth Prospects: Investors might be attracted to AngioDynamics, Inc. (ANGO)'s potential for growth in the medical technology sector, driven by innovative products and expanding market reach.
• Market Position: A strong market position in specific medical device niches can make AngioDynamics, Inc. (ANGO) an attractive investment.

Investment strategies commonly observed among AngioDynamics, Inc. (ANGO) investors include:

• Long-Term Holding: Some investors adopt a buy-and-hold strategy, maintaining their positions for extended periods to benefit from the company's long-term growth and stability.
• Short-Term Trading: Active traders may seek to capitalize on short-term price fluctuations, driven by news, earnings reports, or market sentiment.
• Value Investing: Value investors look for companies that they believe are undervalued by the market, purchasing shares with the expectation that the market will eventually recognize their intrinsic value.

Examining the ownership structure of AngioDynamics, Inc. (ANGO) can provide insights into investor confidence and potential future performance. According to recent data, institutional investors hold a significant percentage of AngioDynamics, Inc. (ANGO)'s outstanding shares. For example, as of January 2024, institutional investors held approximately 94.90% of the company's stock. Some of the top institutional holders include BlackRock Fund Advisors, Vanguard, and Dimensional Fund Advisors LP.

Here is a detailed breakdown of significant institutional holders:

Understanding these ownership details helps to paint a clearer picture of who is invested in AngioDynamics, Inc. (ANGO) and why, offering valuable context for current and prospective investors.

To gain more insights into the financial health of AngioDynamics, Inc. (ANGO), consider exploring Breaking Down AngioDynamics, Inc. (ANGO) Financial Health: Key Insights for Investors.

AngioDynamics, Inc. (ANGO) Institutional Ownership and Major Shareholders of AngioDynamics, Inc. (ANGO)

Institutional ownership in AngioDynamics, Inc. (ANGO) reflects the degree of confidence that large financial entities have in the company's potential. Analyzing the ownership structure provides insights into market sentiment and potential stock price movements.

Here's an overview of AngioDynamics, Inc. (ANGO)'s institutional ownership, recent changes, and the potential impact of these investors:

Top Institutional Investors:

Identifying the top institutional investors in AngioDynamics, Inc. (ANGO) offers a glimpse into who holds significant stakes in the company. These firms often have substantial resources and research capabilities, and their investment decisions can influence market perception.

As of the latest available data, the following are some of the top institutional holders of AngioDynamics, Inc. (ANGO):

• BlackRock Fund Advisors: Holding 1,242,643 shares, representing 3.13% of the company.
• Vanguard Index Funds: Holding 2,842,538 shares, representing 7.16% of the company.
• Dimensional Fund Advisors LP: Holding 1,527,196 shares, representing 3.85% of the company.
• State Street Global Advisors: Holding 828,928 shares, representing 2.09% of the company.

Changes in Ownership:

Monitoring changes in institutional ownership can reveal shifts in sentiment towards AngioDynamics, Inc. (ANGO). Increases in holdings may signal optimism, while decreases could indicate concerns about the company's future performance.

Recent changes in ownership (data from Q1 2024) include:

• Dimensional Fund Advisors LP: Increased their holdings by 123,477 shares in Q1 2024.
• BlackRock Fund Advisors: Increased their holdings by 9,473 shares in Q1 2024.
• Vanguard Index Funds: Increased their holdings by 102,962 shares in Q1 2024.
• State Street Global Advisors: Decreased their holdings by 12,621 shares in Q1 2024.

The following table summarizes institutional ownership in AngioDynamics, Inc. (ANGO):

Impact of Institutional Investors:

Institutional investors can significantly influence AngioDynamics, Inc. (ANGO)’s stock price and strategic direction. Their large trading volumes can drive price movements, and their engagement with company management can shape corporate policy.

Key impacts include:

• Price Stability: High institutional ownership can reduce stock price volatility due to the long-term investment horizons of many institutions.
• Corporate Governance: Institutional investors often engage with company management on issues such as executive compensation, board composition, and strategic initiatives.
• Market Confidence: Increased institutional ownership can signal to the market that AngioDynamics, Inc. (ANGO) is a credible investment, attracting further investment.

Understanding the dynamics of institutional ownership in AngioDynamics, Inc. (ANGO) is crucial for investors seeking to make informed decisions. These large stakeholders play a pivotal role in shaping the company’s market performance and strategic trajectory.

To gain more insights into the company's strategic direction, explore: Mission Statement, Vision, & Core Values of AngioDynamics, Inc. (ANGO).

AngioDynamics, Inc. (ANGO) Key Investors and Their Impact on AngioDynamics, Inc. (ANGO)

Understanding the investor profile of AngioDynamics, Inc. (ANGO) provides critical insights into the company's stability, strategic direction, and potential for growth. Key investors can significantly influence company decisions and stock performance through their holdings and actions.

While specific real-time data on all investors and their recent moves is dynamic and subject to change, examining publicly available information and historical trends can offer a glimpse into the investor landscape of AngioDynamics, Inc. (ANGO). Information regarding major institutional holders, significant individual investors, and any activist investors can shed light on potential influences on the company.

Institutional investors often hold substantial shares in publicly traded companies like AngioDynamics, Inc. (ANGO). These firms include mutual funds, pension funds, hedge funds, and insurance companies. Their investment decisions are driven by in-depth research and analysis, and their trading activity can significantly impact stock prices. Monitoring the holdings of major institutional investors can provide insights into the overall market sentiment toward AngioDynamics, Inc. (ANGO).

Activist investors sometimes take significant stakes in companies with the goal of influencing management decisions and corporate strategy. Their involvement can lead to changes in company policy, restructuring, or even mergers and acquisitions. Identifying any activist investors in AngioDynamics, Inc. (ANGO) and understanding their objectives is crucial for assessing potential shifts in the company's direction.

Recent moves by key investors, such as buying or selling large blocks of shares, can signal important developments. For example, a large purchase by a well-known fund might indicate confidence in the company's future prospects, while a significant sale could raise concerns. Keeping track of these activities can provide valuable clues about the factors driving investor sentiment.

For more in-depth background information, explore: AngioDynamics, Inc. (ANGO): History, Ownership, Mission, How It Works & Makes Money

AngioDynamics, Inc. (ANGO) Market Impact and Investor Sentiment

Understanding investor sentiment and market reactions to AngioDynamics, Inc. (ANGO) requires a close look at its shareholder composition and recent trading activities. Analyzing these factors provides insights into the stock's potential future performance and how major investors perceive the company's prospects.

As of December 31, 2024, AngioDynamics had a mix of institutional, insider, and retail ownership. Institutional investors typically hold the largest percentage of shares, influencing the stock's stability and direction. Insider transactions, such as purchases or sales by company executives, can signal confidence or concern about the company's future. Retail investors also play a role, though their impact is generally less pronounced than that of institutions.

Recent market reactions to changes in ownership or significant investor moves can be telling. For example, a large block of shares being purchased by a prominent investment firm might lead to a short-term price increase, reflecting positive sentiment. Conversely, a major sell-off could trigger a price decline. Monitoring these movements helps gauge market confidence in AngioDynamics, Inc. (ANGO).

Analyst perspectives on key investors can provide additional context. Analysts often assess how major shareholders might influence company strategy, financial performance, and long-term growth. For instance, if a well-known activist investor takes a significant stake, analysts might comment on potential changes in corporate governance or operational efficiencies. These insights are valuable for understanding the broader implications of investor activity.

To illustrate the ownership structure, consider the following hypothetical data based on the fiscal year 2024:

This breakdown shows that institutional investors hold a substantial portion of AngioDynamics' shares, making their sentiment particularly influential. Keeping an eye on their trading activity and any public statements they make can offer valuable clues about the stock's potential direction.

Here are some factors that could influence investor sentiment:

• Company's financial performance (revenue growth, profitability)
• Regulatory approvals for new products
• Market trends in the medical device industry
• Overall economic conditions

Understanding these dynamics is crucial for anyone looking to invest in or follow AngioDynamics, Inc. (ANGO). By tracking ownership changes, market reactions, and analyst opinions, investors can make more informed decisions.

For more insights into the company's strategic direction, explore: Mission Statement, Vision, & Core Values of AngioDynamics, Inc. (ANGO).